| human | Q5 |
| P2798 | Loop ID | 557150 |
| P496 | ORCID iD | 0000-0003-3292-1720 |
| P108 | employer | Yonsei University Health System | Q30254152 |
| P106 | occupation | researcher | Q1650915 |
| Q52590983 | A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes. |
| Q51698376 | Age-dependent gait abnormalities in mice lacking the Rnf170 gene linked to human autosomal-dominant sensory ataxia. |
| Q42647024 | Alterations in Gut Microbiota and Immunity by Dietary Fat. |
| Q64092636 | Atg7-dependent canonical autophagy regulates the degradation of aquaporin 2 in prolonged hypokalemia |
| Q61443221 | Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway |
| Q90460667 | Autophagy in FOXD1 stroma-derived cells regulates renal fibrosis through TGF-β and NLRP3 inflammasome pathway |
| Q90978542 | Autophagy induction can regulate skin pigmentation by causing melanosome degradation in keratinocytes and melanocytes |
| Q38797650 | Autophagy is a major regulator of beta cell insulin homeostasis. |
| Q37005595 | CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis |
| Q38534812 | Effect of mitochondrial stress on systemic metabolism. |
| Q47768810 | Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. |
| Q38538911 | FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs. |
| Q88537974 | Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice |
| Q21996341 | Guidelines for the use and interpretation of assays for monitoring autophagy |
| Q34482945 | Gut Microbiota and Metabolic Disorders |
| Q96136701 | Identification of type 2 diabetes loci in 433,540 East Asian individuals |
| Q96219625 | Innate immune receptors in type 1 diabetes: the relationship to cell death-associated inflammation |
| Q36862693 | Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. |
| Q38947693 | Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. |
| Q92603438 | Mitochondrial Ca2+ Uptake Relieves Palmitate-Induced Cytosolic Ca2+ Overload in MIN6 Cells |
| Q26778766 | New mechanisms of metformin action: Focusing on mitochondria and the gut |
| Q46267786 | Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis |
| Q58705640 | Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches |
| Q94483947 | SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease |
| Q90291594 | TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lysosomal calcium |
| Q49204833 | The Role of Autophagy in Systemic Metabolism and Human-Type Diabetes |
| Q27644656 | p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming |
Search more.